NO20005430D0 - 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmÕter for fremstilling av disse, medisinske preparater inneholdende dem, og mellomprodukter - Google Patents
1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmÕter for fremstilling av disse, medisinske preparater inneholdende dem, og mellomprodukterInfo
- Publication number
- NO20005430D0 NO20005430D0 NO20005430A NO20005430A NO20005430D0 NO 20005430 D0 NO20005430 D0 NO 20005430D0 NO 20005430 A NO20005430 A NO 20005430A NO 20005430 A NO20005430 A NO 20005430A NO 20005430 D0 NO20005430 D0 NO 20005430D0
- Authority
- NO
- Norway
- Prior art keywords
- piperidinyl
- intermediates
- substituted
- methyl
- processes
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 2
- -1 1-substituted-4-piperidinyl Chemical group 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13450498 | 1998-04-28 | ||
JP19501998 | 1998-06-24 | ||
PCT/JP1999/002056 WO1999055674A1 (fr) | 1998-04-28 | 1999-04-19 | Derives de 1-[(1-substituee-4-piperidinyle)methyle]-4-piperidine, procede de production de ceux-ci, compositions medicinales contenant ces composes et intermediaires de ces composes |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20005430D0 true NO20005430D0 (no) | 2000-10-27 |
NO20005430L NO20005430L (no) | 2000-12-20 |
NO318451B1 NO318451B1 (no) | 2005-03-21 |
Family
ID=26468607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005430A NO318451B1 (no) | 1998-04-28 | 2000-10-27 | 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmater for fremstilling av disse, medisinske preparater inneholdende disse, og mellomprodukter for disse forbindelser |
Country Status (23)
Country | Link |
---|---|
US (1) | US6294555B1 (no) |
EP (1) | EP1076055B1 (no) |
KR (1) | KR20010043032A (no) |
CN (1) | CN1118452C (no) |
AR (1) | AR019115A1 (no) |
AT (1) | ATE283260T1 (no) |
AU (1) | AU746406B2 (no) |
BR (1) | BR9909991A (no) |
CA (1) | CA2330475A1 (no) |
DE (1) | DE69922186T2 (no) |
ES (1) | ES2234248T3 (no) |
HK (1) | HK1031869A1 (no) |
HU (1) | HUP0101511A3 (no) |
ID (1) | ID26399A (no) |
IL (1) | IL138568A0 (no) |
NO (1) | NO318451B1 (no) |
NZ (1) | NZ507119A (no) |
PL (1) | PL343726A1 (no) |
PT (1) | PT1076055E (no) |
RU (1) | RU2214400C2 (no) |
SK (1) | SK15852000A3 (no) |
TW (1) | TWI242004B (no) |
WO (1) | WO1999055674A1 (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6344358B1 (en) * | 1999-05-28 | 2002-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
ATE319703T1 (de) | 2001-07-02 | 2006-03-15 | Piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen | |
GB0120461D0 (en) | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
GB0122503D0 (en) | 2001-09-18 | 2001-11-07 | Astrazeneca Ab | Chemical compounds |
SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
US6696468B2 (en) | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
SE0202838D0 (sv) * | 2002-09-24 | 2002-09-24 | Astrazeneca Ab | Chemical compounds |
SE0300957D0 (sv) * | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
WO2005092882A1 (en) * | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
US20050267141A1 (en) * | 2004-05-28 | 2005-12-01 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives |
JP5086091B2 (ja) * | 2004-11-05 | 2012-11-28 | セラヴァンス, インコーポレーテッド | 5−ht4受容体アゴニスト化合物 |
EP1807423B1 (en) * | 2004-11-05 | 2009-05-20 | Theravance, Inc. | Quinolinone-carboxamide compounds |
ES2347265T3 (es) * | 2004-12-22 | 2010-10-27 | Theravance, Inc. | Compuestos de indazol-carboxamida. |
ES2523851T3 (es) * | 2005-03-02 | 2014-12-02 | Theravance Biopharma R&D Ip, Llc | Compuestos de quinolinona como agonistas de los receptores 5-HT4 |
US7256294B2 (en) * | 2005-05-25 | 2007-08-14 | Theravance, Inc. | Crystalline form of a benzimidazole-carboxamide medicinal compound |
MY147756A (en) | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
JP2009501793A (ja) | 2005-07-21 | 2009-01-22 | アストラゼネカ・アクチエボラーグ | 新規ピペリジン誘導体 |
TWI423967B (zh) * | 2008-02-21 | 2014-01-21 | Dainippon Sumitomo Pharma Co | 醯胺衍生物及含有其之醫藥組合物 |
US8642772B2 (en) | 2008-10-14 | 2014-02-04 | Sk Biopharmaceuticals Co., Ltd. | Piperidine compounds, pharmaceutical composition comprising the same and its use |
US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
CN102781436B (zh) | 2009-11-06 | 2014-01-08 | 爱思开生物制药株式会社 | 纤维肌痛综合征的治疗方法 |
ES2447295T3 (es) | 2009-11-06 | 2014-03-11 | Sk Biopharmaceuticals Co., Ltd. | Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
GB2511685A (en) | 2011-11-18 | 2014-09-10 | Heptares Therapeutics Ltd | Muscarinic m1 receptor agonists |
GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
WO2017137910A1 (en) * | 2016-02-11 | 2017-08-17 | Symed Labs Limited | Processes for the preparation of highly pure prucalopride succinate and its intermediates |
GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
CN110950843B (zh) * | 2019-11-28 | 2022-12-27 | 广东东阳光药业有限公司 | 取代的苯酰胺衍生物及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9005014D0 (en) | 1990-03-06 | 1990-05-02 | Janssen Pharmaceutica Nv | N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives |
GB9204565D0 (en) | 1992-03-03 | 1992-04-15 | Smithkline Beecham Plc | Pharmaceuticals |
US5864039A (en) | 1994-03-30 | 1999-01-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and use thereof as medicaments |
DE69632728T2 (de) * | 1995-04-28 | 2004-10-14 | Banyu Pharmaceutical Co., Ltd. | 1,4-disubstituierte piperidinderivate |
JPH111472A (ja) | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
-
1999
- 1999-04-19 KR KR1020007011894A patent/KR20010043032A/ko not_active Application Discontinuation
- 1999-04-19 DE DE69922186T patent/DE69922186T2/de not_active Expired - Fee Related
- 1999-04-19 PT PT99913701T patent/PT1076055E/pt unknown
- 1999-04-19 US US09/674,162 patent/US6294555B1/en not_active Expired - Fee Related
- 1999-04-19 RU RU2000129161/04A patent/RU2214400C2/ru not_active IP Right Cessation
- 1999-04-19 IL IL13856899A patent/IL138568A0/xx unknown
- 1999-04-19 PL PL99343726A patent/PL343726A1/xx unknown
- 1999-04-19 CA CA002330475A patent/CA2330475A1/en not_active Abandoned
- 1999-04-19 WO PCT/JP1999/002056 patent/WO1999055674A1/ja not_active Application Discontinuation
- 1999-04-19 EP EP99913701A patent/EP1076055B1/en not_active Expired - Lifetime
- 1999-04-19 AT AT99913701T patent/ATE283260T1/de not_active IP Right Cessation
- 1999-04-19 BR BR9909991-8A patent/BR9909991A/pt not_active IP Right Cessation
- 1999-04-19 CN CN99805583A patent/CN1118452C/zh not_active Expired - Fee Related
- 1999-04-19 ES ES99913701T patent/ES2234248T3/es not_active Expired - Lifetime
- 1999-04-19 TW TW088106200A patent/TWI242004B/zh active
- 1999-04-19 SK SK1585-2000A patent/SK15852000A3/sk unknown
- 1999-04-19 NZ NZ507119A patent/NZ507119A/xx unknown
- 1999-04-19 HU HU0101511A patent/HUP0101511A3/hu unknown
- 1999-04-19 AU AU31716/99A patent/AU746406B2/en not_active Ceased
- 1999-04-19 ID IDW20002107A patent/ID26399A/id unknown
- 1999-04-28 AR ARP990101966A patent/AR019115A1/es unknown
-
2000
- 2000-10-27 NO NO20005430A patent/NO318451B1/no unknown
-
2001
- 2001-03-28 HK HK01102252A patent/HK1031869A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1076055A4 (en) | 2001-07-18 |
CN1118452C (zh) | 2003-08-20 |
CA2330475A1 (en) | 1999-11-04 |
US6294555B1 (en) | 2001-09-25 |
CN1298391A (zh) | 2001-06-06 |
EP1076055A1 (en) | 2001-02-14 |
IL138568A0 (en) | 2001-10-31 |
NO318451B1 (no) | 2005-03-21 |
AU3171699A (en) | 1999-11-16 |
RU2214400C2 (ru) | 2003-10-20 |
ATE283260T1 (de) | 2004-12-15 |
HK1031869A1 (en) | 2001-06-29 |
HUP0101511A2 (hu) | 2001-09-28 |
AR019115A1 (es) | 2001-12-26 |
WO1999055674A1 (fr) | 1999-11-04 |
DE69922186D1 (de) | 2004-12-30 |
AU746406B2 (en) | 2002-05-02 |
PT1076055E (pt) | 2005-02-28 |
BR9909991A (pt) | 2000-12-26 |
NO20005430L (no) | 2000-12-20 |
ID26399A (id) | 2000-12-21 |
DE69922186T2 (de) | 2005-05-04 |
ES2234248T3 (es) | 2005-06-16 |
SK15852000A3 (sk) | 2001-06-11 |
PL343726A1 (en) | 2001-09-10 |
NZ507119A (en) | 2002-08-28 |
TWI242004B (en) | 2005-10-21 |
HUP0101511A3 (en) | 2002-12-28 |
EP1076055B1 (en) | 2004-11-24 |
KR20010043032A (ko) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20005430D0 (no) | 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmÕter for fremstilling av disse, medisinske preparater inneholdende dem, og mellomprodukter | |
NO20002835D0 (no) | 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor | |
NO20001409D0 (no) | Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger | |
NO20021401D0 (no) | Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser | |
DK1117645T3 (da) | Arylsubstituerede propanolaminderivater, fremgangsmåder til fremstilling deraf, lægemidler indeholdende disse forbindelser og anvendelse deraf | |
NO20014013L (no) | 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem | |
DK1156049T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
DK1202965T3 (da) | Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse | |
NO991130D0 (no) | Modifiserte aminosyrer, farmas°ytiske preparater som inneholder disse forbindelsene og fremgangsmÕter for fremstilling derav | |
NO993868D0 (no) | 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike | |
HUP0201711A3 (en) | N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them | |
HUP0103793A3 (en) | N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them | |
NO305075B1 (no) | Glycinamid-derivater, farmas°ytiske medikamenter som inneholder dem og mellomprodukter for fremstilling av dem | |
NO20015309L (no) | 1- (P-tienylbenzyl)-imidazoler som anginotensin-(1-7) reseptoragonister, fremgangsmåte for fremstilling og anvendelse avde samme og farmasöytiske preparater som inneholder nevnteforbindelser | |
DK0885204T3 (da) | Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser | |
NO20003662L (no) | Syntetiske polysakkarider, fremgangsmÕte for fremstilling derav og farmasøytiske preparater inneholdende slike | |
HRP980258B1 (en) | New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them | |
DK0868911T3 (da) | Rapamycinpræparater til oral indgivelse | |
DK0842927T3 (da) | 3-Amido-chromanylsulfonyl(thio)urinstoffer, fremgangsmåder til deres fremstilling, deres anvendelse og farmaceutiske præparater med indhold deraf | |
DK0838469T3 (da) | 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser | |
EE200300135A (et) | Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid | |
DK1210348T3 (da) | Naphthyridinderivater, fremgangsmåde til deres fremstilling, deres anvendelse og farmaceutiske præparater omfattende dem | |
NO20003290L (no) | N-fenylamid- og N-pyridylamidderivater, fremgangsmÕte for fremstilling av dem, og farmasøytiske preparater som inneholder dem | |
NO20013878L (no) | (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme | |
NO20014803L (no) | Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem |